Drug-Specific Design of Telodendrimer Architecture for Effective Doxorubicin Encapsulation

Wenjuan Jiang, Xiaoyi Wang, Dandan Guo, Juntao Luo, Shikha Nangia

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Designing a versatile nanocarrier platform that can be tailored to deliver specific drug payloads is challenging. In general, effective drug encapsulation, high drug-loading capacity, uniform shape and size distribution, and enhanced stability are among the fundamental attributes of a successful nanocarrier design. These physiochemical features of the nanocarriers are intimately tied to the specific drug payload that they are tasked to deliver. The molecular architecture of the nanocarrier's scaffold often needs to be tuned for each drug, especially if the target drugs are structurally and chemically distinct as in the case of doxorubicin (DOX) and paclitaxel (PTX). Starting from our previously reported telodendrimeric block copolymer platform optimized for PTX, we analyze three generations of telodendrimer architectures to arrive at the design that is capable of encapsulating another important chemotherapeutic drug, DOX. Multiple long-time-scale self-assembly simulations were performed both in atomistic and coarse-grained resolutions to generate equilibrated DOX-encapsulated nanocarriers. The results show how subtle changes in the molecular architecture of the telodendrimer head groups have profound effects on the nanocarrier size, morphology, and asphericity. The simulation results are in agreement with the experimental data for DOX-encapsulated nanocarriers. This work emphasizes the increasing role of molecular simulations in the rational design of nanocarriers, thereby eliminating the trial and error method that has been prevalent in experimental synthesis. The molecular-level insights gained from the simulations will be used to design the next generation of drug-specific nanocarriers.

Original languageEnglish (US)
Pages (from-to)9766-9777
Number of pages12
JournalJournal of Physical Chemistry B
Volume120
Issue number36
DOIs
StatePublished - Sep 15 2016
Externally publishedYes

Fingerprint

Encapsulation
Doxorubicin
drugs
Pharmaceutical Preparations
Paclitaxel
payloads
Scaffolds
Self assembly
Block copolymers
platforms
simulation
asphericity
encapsulating
block copolymers
self assembly
synthesis

ASJC Scopus subject areas

  • Physical and Theoretical Chemistry
  • Surfaces, Coatings and Films
  • Materials Chemistry

Cite this

Drug-Specific Design of Telodendrimer Architecture for Effective Doxorubicin Encapsulation. / Jiang, Wenjuan; Wang, Xiaoyi; Guo, Dandan; Luo, Juntao; Nangia, Shikha.

In: Journal of Physical Chemistry B, Vol. 120, No. 36, 15.09.2016, p. 9766-9777.

Research output: Contribution to journalArticle

Jiang, Wenjuan ; Wang, Xiaoyi ; Guo, Dandan ; Luo, Juntao ; Nangia, Shikha. / Drug-Specific Design of Telodendrimer Architecture for Effective Doxorubicin Encapsulation. In: Journal of Physical Chemistry B. 2016 ; Vol. 120, No. 36. pp. 9766-9777.
@article{eb869bef813a458197308bbe3d6f3f90,
title = "Drug-Specific Design of Telodendrimer Architecture for Effective Doxorubicin Encapsulation",
abstract = "Designing a versatile nanocarrier platform that can be tailored to deliver specific drug payloads is challenging. In general, effective drug encapsulation, high drug-loading capacity, uniform shape and size distribution, and enhanced stability are among the fundamental attributes of a successful nanocarrier design. These physiochemical features of the nanocarriers are intimately tied to the specific drug payload that they are tasked to deliver. The molecular architecture of the nanocarrier's scaffold often needs to be tuned for each drug, especially if the target drugs are structurally and chemically distinct as in the case of doxorubicin (DOX) and paclitaxel (PTX). Starting from our previously reported telodendrimeric block copolymer platform optimized for PTX, we analyze three generations of telodendrimer architectures to arrive at the design that is capable of encapsulating another important chemotherapeutic drug, DOX. Multiple long-time-scale self-assembly simulations were performed both in atomistic and coarse-grained resolutions to generate equilibrated DOX-encapsulated nanocarriers. The results show how subtle changes in the molecular architecture of the telodendrimer head groups have profound effects on the nanocarrier size, morphology, and asphericity. The simulation results are in agreement with the experimental data for DOX-encapsulated nanocarriers. This work emphasizes the increasing role of molecular simulations in the rational design of nanocarriers, thereby eliminating the trial and error method that has been prevalent in experimental synthesis. The molecular-level insights gained from the simulations will be used to design the next generation of drug-specific nanocarriers.",
author = "Wenjuan Jiang and Xiaoyi Wang and Dandan Guo and Juntao Luo and Shikha Nangia",
year = "2016",
month = "9",
day = "15",
doi = "10.1021/acs.jpcb.6b06070",
language = "English (US)",
volume = "120",
pages = "9766--9777",
journal = "Journal of Physical Chemistry B Materials",
issn = "1520-6106",
publisher = "American Chemical Society",
number = "36",

}

TY - JOUR

T1 - Drug-Specific Design of Telodendrimer Architecture for Effective Doxorubicin Encapsulation

AU - Jiang, Wenjuan

AU - Wang, Xiaoyi

AU - Guo, Dandan

AU - Luo, Juntao

AU - Nangia, Shikha

PY - 2016/9/15

Y1 - 2016/9/15

N2 - Designing a versatile nanocarrier platform that can be tailored to deliver specific drug payloads is challenging. In general, effective drug encapsulation, high drug-loading capacity, uniform shape and size distribution, and enhanced stability are among the fundamental attributes of a successful nanocarrier design. These physiochemical features of the nanocarriers are intimately tied to the specific drug payload that they are tasked to deliver. The molecular architecture of the nanocarrier's scaffold often needs to be tuned for each drug, especially if the target drugs are structurally and chemically distinct as in the case of doxorubicin (DOX) and paclitaxel (PTX). Starting from our previously reported telodendrimeric block copolymer platform optimized for PTX, we analyze three generations of telodendrimer architectures to arrive at the design that is capable of encapsulating another important chemotherapeutic drug, DOX. Multiple long-time-scale self-assembly simulations were performed both in atomistic and coarse-grained resolutions to generate equilibrated DOX-encapsulated nanocarriers. The results show how subtle changes in the molecular architecture of the telodendrimer head groups have profound effects on the nanocarrier size, morphology, and asphericity. The simulation results are in agreement with the experimental data for DOX-encapsulated nanocarriers. This work emphasizes the increasing role of molecular simulations in the rational design of nanocarriers, thereby eliminating the trial and error method that has been prevalent in experimental synthesis. The molecular-level insights gained from the simulations will be used to design the next generation of drug-specific nanocarriers.

AB - Designing a versatile nanocarrier platform that can be tailored to deliver specific drug payloads is challenging. In general, effective drug encapsulation, high drug-loading capacity, uniform shape and size distribution, and enhanced stability are among the fundamental attributes of a successful nanocarrier design. These physiochemical features of the nanocarriers are intimately tied to the specific drug payload that they are tasked to deliver. The molecular architecture of the nanocarrier's scaffold often needs to be tuned for each drug, especially if the target drugs are structurally and chemically distinct as in the case of doxorubicin (DOX) and paclitaxel (PTX). Starting from our previously reported telodendrimeric block copolymer platform optimized for PTX, we analyze three generations of telodendrimer architectures to arrive at the design that is capable of encapsulating another important chemotherapeutic drug, DOX. Multiple long-time-scale self-assembly simulations were performed both in atomistic and coarse-grained resolutions to generate equilibrated DOX-encapsulated nanocarriers. The results show how subtle changes in the molecular architecture of the telodendrimer head groups have profound effects on the nanocarrier size, morphology, and asphericity. The simulation results are in agreement with the experimental data for DOX-encapsulated nanocarriers. This work emphasizes the increasing role of molecular simulations in the rational design of nanocarriers, thereby eliminating the trial and error method that has been prevalent in experimental synthesis. The molecular-level insights gained from the simulations will be used to design the next generation of drug-specific nanocarriers.

UR - http://www.scopus.com/inward/record.url?scp=84987827726&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84987827726&partnerID=8YFLogxK

U2 - 10.1021/acs.jpcb.6b06070

DO - 10.1021/acs.jpcb.6b06070

M3 - Article

AN - SCOPUS:84987827726

VL - 120

SP - 9766

EP - 9777

JO - Journal of Physical Chemistry B Materials

JF - Journal of Physical Chemistry B Materials

SN - 1520-6106

IS - 36

ER -